Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Safety and Toxicity Study of Cisplatin With or Without Cetuximab and Concomitant Radiotherapy for Locoregionally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)

NCT01301248 is registered in ClinicalTrials.gov with Theagenio Cancer Hospital as lead sponsor.

NCT NCT01301248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01301248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Safety and Toxicity Study of Cisplatin With or Without Cetuximab and Concomitant Radiotherapy for Locoregionally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)
Lead sponsor
Theagenio Cancer Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 2008
Completion date
June 30, 2011
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ajcc stage iii/iv, head and neck neoplasms